Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D supplementation and cardiovascular risk factors in adults with low 25-hydroxyvitamin D
2013-003514-40Phase 4Completed
- Sponsor
- University Hospital of North Norway
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Vitamin D deficiency (VDD) and cardiac risk factors comparing Dekristol (vitamin D) supplementation with Placebo (2 arms). Primary endpoint: Change in cardiovascular risk factors at 3 months. Started Aug 2013; status: completed.
02
Drugs
cholecalciferol
03
Conditions
Vitamin D deficiency (VDD)cardiac risk factors
Beyond the preview
Go deeper on 2013-003514-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003514-40.